EKER, S. S. Et Al. 2017. Can serum level of BDNF be used as a biomarker in distinction between the depressive episodes of bipolar disorder and recurrent major depressive disorder?. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , vol.18, no.2 , 108-112.

EKER, S. S., Sarikavakli, U., CANGÜR, Ş., & AKKAYA, C., (2017). Can serum level of BDNF be used as a biomarker in distinction between the depressive episodes of bipolar disorder and recurrent major depressive disorder?. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , vol.18, no.2, 108-112.

EKER, SALİH Et Al. "Can serum level of BDNF be used as a biomarker in distinction between the depressive episodes of bipolar disorder and recurrent major depressive disorder?," ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , vol.18, no.2, 108-112, 2017

EKER, SALİH S. Et Al. "Can serum level of BDNF be used as a biomarker in distinction between the depressive episodes of bipolar disorder and recurrent major depressive disorder?." ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , vol.18, no.2, pp.108-112, 2017

EKER, S. S. Et Al. (2017) . "Can serum level of BDNF be used as a biomarker in distinction between the depressive episodes of bipolar disorder and recurrent major depressive disorder?." ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , vol.18, no.2, pp.108-112.

@article{article, author={SALİH SAYGIN EKER Et Al. }, title={Can serum level of BDNF be used as a biomarker in distinction between the depressive episodes of bipolar disorder and recurrent major depressive disorder?}, journal={ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY}, year=2017, pages={108-112} }